Cyclopropyl group substituted oxazolidinone antibiotics and...

Details Cyclopropyl group substituted oxazolidinone antibiotics and... Cyclopropyl group substituted oxazolidinone antibiotics and...

2004-06-29

2008-12-09

Shameem, Golam M. M. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S376000, C546S271400, C548S229000

Reexamination Certificate

active

07462633

ABSTRACT:
This invention relates to new oxazolidinones having a cyclopropyl moiety, which are effective against aerobic and anerobic pathogens such as multi-resistantstaphylococci, streptococciandenterococci, Bacteroidesspp.,Clostridiaspp. species, as well as acid-fast organisms such asMycobacterium tuberculosisand other mycobacterial species.The compounds are represented by structural formula I:its enantiomer, diastereomer, or pharmaceutically acceptable salt or ester thereof.

REFERENCES:
patent: 4053593 (1977-10-01), Frumoff
patent: 5523403 (1996-06-01), Barbachyn
patent: 5565571 (1996-10-01), Barbachyn et al.
patent: 5627181 (1997-05-01), Riedl et al.
patent: 5736545 (1998-04-01), Gadwood et al.
patent: 6069160 (2000-05-01), Stolle et al.
patent: 6686363 (2004-02-01), Fukuda
patent: 6689779 (2004-02-01), Lee et al.
patent: 7192974 (2007-03-01), Gravestock et al.
patent: 2002/0103186 (2002-08-01), Mehta et al.
patent: 2002/0161029 (2002-10-01), Paget et al.
patent: 2003/0125367 (2003-07-01), Fukuda et al.
patent: 2003/0225107 (2003-12-01), Fukuda et al.
patent: 2004/0147760 (2004-07-01), Thomas et al.
patent: 2005/0203144 (2005-09-01), Fukuda et al.
patent: 2007/0185132 (2007-08-01), Fukuda
patent: 2007/0203187 (2007-08-01), Fukuda
patent: 2007/0293493 (2007-12-01), Hammond et al.
patent: 2 415 965 (2002-01-01), None
patent: 0 352 0 781 (1990-01-01), None
patent: 0 352 0781 (1990-01-01), None
patent: 0 657 440 (1995-06-01), None
patent: WO 94/13649 (1994-06-01), None
patent: WO 96/35691 (1996-11-01), None
patent: WO 01/58885 (2001-08-01), None
patent: WO 01/81350 (2001-11-01), None
patent: WO 01/94342 (2001-12-01), None
patent: WO 02/06278 (2002-01-01), None
patent: WO 02/051819 (2002-07-01), None
patent: WO 02/059116 (2002-08-01), None
patent: WO 03/027083 (2003-04-01), None
patent: WO 03/048136 (2003-06-01), None
patent: WO 03/063862 (2003-08-01), None
patent: WO 03/072553 (2003-09-01), None
patent: WO 03/072575 (2003-09-01), None
patent: WO 03/097059 (2003-11-01), None
patent: WO 2004/033451 (2004-04-01), None
patent: WO 2004/048350 (2004-06-01), None
patent: WO 2004/089943 (2004-10-01), None
patent: WO 2004/099199 (2004-11-01), None
patent: WO 2005/005398 (2005-01-01), None
patent: WO 2005/005399 (2005-01-01), None
patent: WO 2005/005420 (2005-01-01), None
patent: WO 2005/005422 (2005-01-01), None
CAPLUS 2003:576097; 556801-55-9, 556801-57-1, 556801-58-2, 556801-59-3, 556801-62-8, 556801-63-9, 556801-64-0; 556801-61-7P.
Riedl et al., Exp. Opin. Ther. Patents (1999) 9(5).
Ford et al., Trends in Microbilogy, 196. vol. 5, May 1997.
Wolff, Manfred, Burger's Medicinal Chemistry 5th Ed. Part I, John Wiley & Sons, 1995, pp. 975-77
Banker, GS, et al., “Modern Pharmaceuticals” 3rd Ed. Marcel Dekker, New York, 1996, pp. 451 & 596.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Fleming et al., Expert Opinion on Pharmacotherapy, 2007, 8(4) 415-426.
Vippangunta et al., Advanced Drug delivery Reviews, 2001, 48: 3-26.
March, Jerry, Advanced Org. Chemistry, 1992, New York; John Wiley & Sons, pp. 771 & 1224.
Gladstone et al., Newer Formations of the Tripants, Drugs, 2003, 63(21) pp. 2285-2305.
Carey et al., Advanced Org. Chemistry, 3rd Ed. 1990, New York: Plenum Press, pp. 617-618.
Ammazzolorso et al., II Farmaco, 2004, pp. 686-690.
CAPLUS Database aceesion # 139: 85332.
Database Caplus, Chemical Abstracts Service, Columbus Ohio, US; XP002302363, retrieved from CAPLUS accension No. 2003:576097, Database accesion No. 139:85332 (Equivalent to CN1355165).
M.D. Mashkovsy, “Medicaments” part 1, p. 8 (Moscow 1993).

Affiliated with

Also associated with

Rating

Cyclopropyl group substituted oxazolidinone antibiotics and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclopropyl group substituted oxazolidinone antibiotics and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopropyl group substituted oxazolidinone antibiotics and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4033745